TLR4 and neoplasm: To separate direct GLA effects on tumor cells from effects of GLA on immune cells in the TME, we pretreated A20 WT cells or A20 TLR4 k.o. cells with GLA-AF (5 μg /ml) in vitro for 48 h prior to subcutaneous implantation.